Urigen Pharmaceuticals is a biochemical research and development company focused on the creation of cardiovascular therapeutics. The company begins development at a stage of a known molecule or protein and applies its expertise in formulation, manufacturing, clinical development and regulatory affairs to create products that fill unmet medical needs. Urigen Pharmaceuticals has a series of technologies that allow the company to generate novel therapeutics to treat a wide range of diseases. The company s technologies are applied by its collaborators for the development of therapeutics to treat a variety of indications, including infectious diseases and cancer. In addition to its own products, it has developed a series of technologies that it licensed to biotechnology and pharmaceutical companies. Urigen Pharmaceuticals maintains a location in Burlingame, Calif.